Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,234 | -25,202 | -13,700 | N/A | -7,391 |
| Depreciation Amortization | 72 | 50 | 34 | N/A | 7 |
| Other Working Capital | 3,069 | 2,536 | -771 | N/A | -83 |
| Other Operating Activity | 2,012 | 871 | 880 | 0 | -9,778 |
| Operating Cash Flow | $-22,081 | $-21,745 | $-13,557 | $N/A | $-17,245 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 24,124 | -18,527 | N/A | N/A |
| PPE Investments | N/A | -4 | -6 | N/A | -8 |
| Other Investing Activity | -502 | -569 | -357 | 0 | -183 |
| Investing Cash Flow | $-502 | $23,551 | $-18,890 | $N/A | $-191 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,999 | 15,885 | 33,090 | N/A | 18,265 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 600 |
| Financing Cash Flow | $4,999 | $15,885 | $33,090 | $N/A | $18,865 |
| Beginning Cash Position | 19,470 | 1,779 | 1,136 | N/A | 736 |
| End Cash Position | 1,886 | 19,470 | 1,779 | N/A | 2,165 |
| Net Cash Flow | $-17,584 | $17,691 | $643 | $N/A | $1,429 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,081 | -21,745 | -13,557 | N/A | -17,245 |
| Capital Expenditure | N/A | -4 | -6 | N/A | -8 |
| Free Cash Flow | -22,081 | -21,749 | -13,563 | 0 | -17,253 |